LONDON (Alliance News) – Electrical Geodesics Inc on Thursday said it has signed a two-year deal with ElMindA to provide its GES 400 systems to the US-Israeli company’s Brain Network Activation platform.
The BNA platform is an analysis system which received clearance from the US Food and Drug Administration last year for the assessment of brain function in 14-to-24-year-olds.
Under the deal, Electrical Geodesics will supply and support customers of ElMindA who buy the BNA analysis system with its GES 400 dense array EEG systems on pre-determined terms. It did not provide financial details of the deal.
“We have worked with ElMindA over a number of years and are pleased that their research efforts have led to the BNA system receiving FDA clearance. ElMindA recognises the need for the precision dense array EEG provides to enable objective assessment of brain disorders and injuries,” said Electrical Geodesics Chief Executive Officer Don Tucker.
See the PM talk about BNA at: